Fecal microbiome transplantation reverses obesity-induced neuropathic pain

Keywords: Editorial


Download data is not yet available.


Fond GB, Lagier JC, Honore S, Lancon C, Korchia T, Sunhary De Verville PL, Llorca PM, Auquier P, Guedj E, Boyer L. Microbiota-orientated treatments for major depression and schizophrenia. Nutrients 2020; 12(4): 1024.

Holvoet T, Joossens M, Vázquez-Castellanos JF, Christiaens E, Heyerick L, Boelens J, Verhasselt B, van Vlierberghe H, De Vos M, Raes J, De Looze D. Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: Short- and long-term results from a placebo-controlled randomized trial. Gastroenterology 2020; 15: S0016-5085(20)34937-4.

Bonomo RR, Cook TM, Gavini CK, White CR, Jones JR, Bovo E, Zima AV, Brown IA, Dugas LR, Zakharian E, Aubert G, Alonzo F 3rd, Calcutt NA, Mansuy-Aubert V. Fecal transplantation and butyrate improve neuropathic pain, modify immune cell profile, and gene expression in the PNS of obese mice. Proc Natl Acad Sci USA 2020; 117(42): 26482-26493.

Xiang L, Ding X, Li Q, Wu X, Dai M, Long C, He Z, Cui B, Zhang F. Efficacy of faecal microbiota transplantation in Crohn's disease: a new target treatment? Microb Biotechnol 2020; 13(3): 760-769.

How to Cite
Granados-Soto , V. (2021). Fecal microbiome transplantation reverses obesity-induced neuropathic pain. Mexican Journal of Medical Research ICSA, 9(17), 1-2. https://doi.org/10.29057/mjmr.v9i17.6696